This inventor holds 1 USPTO granted patent. Top assignee: Noxxon Pharma Ag. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Simone Schulzchen: Innovator in Nucleic Acid Technology
Introduction
Simone Schulzchen is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of nucleic acid technology. Her innovative work has led to the development of a unique nucleic acid molecule that specifically binds to CGRP.
Latest Patents
Simone holds 1 patent related to her invention of nucleic acids specifically binding CGRP. This invention involves a nucleic acid molecule capable of binding to CGRP, featuring a central stretch of nucleotides with a specific sequence. The detailed composition of the nucleotides includes various ribonucleotides and 2′-deoxyribonucleotides, showcasing her expertise in molecular biology.
Career Highlights
Simone is currently employed at Noxxon Pharma AG, where she continues to advance her research and development efforts. Her work at the company focuses on innovative solutions in the pharmaceutical industry, particularly in the area of nucleic acid therapies.
Collaborations
Throughout her career, Simone has collaborated with notable colleagues such as Werner Purschke and Florian Jarosch. These partnerships have contributed to her success and the advancement of her research initiatives.
Conclusion
Simone Schulzchen is a trailblazer in the field of nucleic acid technology, with her innovative patent reflecting her dedication to scientific advancement. Her contributions continue to impact the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile